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I.

Introduction

Human embryonic stem cells (hESCs) are cells derived from 5-day human embryos and are selfrenewing cell lines that change into any type of cell in the body, a trait called pluripotency.
hESCs have almost unlimited clinical and medical research potential. After months growing in
culture media, these captivating cells maintain the ability to form cells ranging from skeletal to
muscle to nerve, and potentially any cell type that comprise the body (“Human embryonic stem
cell research,” 2006). Their proliferative and innovative potential promises a fundamentally
unlimited supply of different cell types for transplantation in disorders ranging from heart
disease to muscular sclerosis to spinal cord injury (Stoltz, 2012). Despite the great therapeutic
promise of hESC research, it comes with a controversial ethical debate due to its involvement
with the destruction of the human embryo. The central argument revolves around the question of
whether or not these human embryos should be ascribed equal moral status to fully developed
humans (Holland, 2012). Opponents of hESC research argue that hESC research is morally
wrong as it involves the unjust killing of human beings. This controversy raises many
philosophical and moral questions such as, what constitutes the beginning of the existence of a
human being, the moral status of human embryos, and the case of embryos already being
destroyed being utilized for the greater good in clinical research.
There are many identifying traits which one has that shapes their moral beliefs and social
existence—thus, affecting their views on hESC research. One of the biggest influential factors in
this matter is religious and cultural traditions. Most faiths have a general view on hESC research
based on their beliefs on the moral status of the early human embryo. With this, most nation’s
policies on hESC research align well with the predominate religious and cultural views of its
people. However, there are some countries in which their policies on hESC research conflicts
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with their general religious and cultural views. This can be partly attributed to the many other
factors that play a role in one’s view on hESC research; this includes, age, education,
socioeconomic status, race, political ideology, and region of residence.
This thesis aims to analyze the origin and advancements of human embryonic stem cells, as well
as philosophical, ethical, sociocultural, and political aspects. The analysis will include an
investigation of the many underlying attributes of an individual that affect their views on hESC
research and two specific nations that have hESC policies that conflict with their religious and
cultural views. This thesis aims to make a valid conclusion on the reasoning behind each faith’s
stance on hESC research, utilize the predominate religion in each nation to better understand
their political stance on hESC research, and find any inconsistencies in a region’s cultural and
political views.
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II.

The Science and Origin of Human Embryonic Stem Cells (hESC)

In 1998, Dr. J.A Thomson derived the first-ever human embryonic stem cell (hESC) line, which
is self-renewing and pluripotent. Researchers utilized the 36 embryos to isolate 14 inner cell
masses (ICMs) and derived five hESC lines. The embryos were donated by 36 patients after
undergoing IVF treatment. hESCs are derived in vitro (in vitro studies are performed with cells
outside their normal biological context) around the fifth day of an embryo’s development
(Thomson et al. 1998). A day 5 embryo consists of 200-250 cells that mostly make up the
trophoblast (the outermost layer of blastocysts) and is when the first differentiation is observed
and the ICM emerges. These ICM cells are pluripotent and once harvested can now undergo
mitosis indefinitely in cell cultures (Dupont et al., 2019).
hESCs are derived from the ICM of the blastocyst, requiring the removal of the trophoblast,
which ultimately prevents the blastocysts potential for further development. This led to the
ongoing controversial debate regarding the ethics of utilizing hESCs in research as it involves the
destruction of the human embryo (“Human embryonic stem cell research,” 2006). However, the
hESCs have unlimited research potential and can be used for treating life-threatening diseases
and conditions.
Due to their self-renewing and pluripotent characteristics, hESCs are a really attractive cell
source for regenerative medicine, where they are successful in repairing tissue damage and
replacing certain cells lost due to disease (Stoltz, 2012). hESCs must be differentiated before
they can be used in a clinical sense. For hESCs to differentiate into mature cells, embryoid
bodies (hEBs) have to be created. hEBs are produced by the accumulation of embryonic cells
and the inhibition of cells separating into germ lines (“Human embryonic stem cell research,”
2006). After the hEBs are isolated, they can be induced to produce many different types of cells
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including neuronal and myogenic (Stoltz, 2012). hESCs provide unparalleled information on
early development—providing researchers the ability to analyze how a single original cell
differentiates into many different types of cells, with an immeasurable amount of forms and
functions. Ultimately, these cells have been shown to be successful in modeling an array of
diseases and therapies, which can be utilized in future treatment plans in some medical
conditions.

Figure 1: Use of inner cell mass pluripotent stem cells and their stimulation to differentiate into
desired cell types.
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III.

Biomedical Perspective

A. Human Embryonic Stem Cell’s Potential in Medical Applications Overview
The first 15 years of hESC research was based on an understanding of the molecular pathways
behind pluripotency (Cyranoski, 2018). This research led to the discovery of hESC’s tremendous
potential in regenerative medicine by injecting the healthy cells derived from them, which allows
the permanent repair of damaged tissues and organs in the body (Stoltz, 2012). This is significant
to the current medical practices as an innovative treatment of the disease to stop the progression
of it but also to restore the affected organ. For example, patients suffering from myocardial
infarction would be treated by not only inhibiting the progression of the event but also repairing
the heart tissue. Similarly, patients with spinal cord injuries could have cell-based treatments that
would reinstate their central nervous system function. Regenerative medicine would create a
paradigm shift in clinical and medical therapeutics. About 30 clinical trials are currently ongoing
with hESC-derived cells that could potentially revolutionize medical practices (Eguizabal et al.
2019).
hESCs’ inherent abilities (such as, indefinite proliferation, pluripotency, and genotypic
normalcy) have given scientists and researchers the opportunity to create boundless applications
to disease treatment, cell therapy, and regenerative medicine (Dupont et al., 2019).

B. Regenerative Medicine
a. Human Embryonic Stem Cells in Heart Regeneration
hESCs are being investigated in their utilization in cell-based heart repair as they can be
driven in vitro towards a cardiomyogenic cell line (cardiomyocyte producing). These cells can
embed into infarct areas (tissue death due to the inadequate blood supply to the area) and
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differentiate into cardiomyocytes where they ultimately improve heart function (Xiong et al.
2011). In 2014, a clinical study was done in France, where a fibrin patch embedded with hESCderived cardiac progenitors was transplanted into epicardium of the infarcted area in the heart.
The first patient suffering from severe heart failure New York Heart Association (NYHA)
functional Class III improved to NYHA Class I and remained stable NYHA Class I 6-months
after the treatment (Stoltz, 2012). This is a tremendous breakthrough in clinical and medical
applications and sets the framework for further research in the field.
hESC derived cardiomyocytes have been shown to be successful in remuscularization of
infarcted hearts (in rats, guinea pigs, and monkeys), where there is an overall higher preservation
of cardiac function. However, there are some limitations such as small graft size and insufficient
proliferation. Recently, hESC derived epicardium (the origin for cardiac fibroblasts and coronary
smooth muscle) has successfully enhanced hESC-CM proliferation and maturation in infarcted
hearts, which creates larger grafts enhancing ventricular function. hESC derived epicardium
supports the development of 3D-EHT (3 dimensional engineered heart tissues) through
cardiomyocyte maturation and proliferation in vitro and in vivo (Bargehr et al., 2019). The
epicardium tremendously increased cardiomyocyte function and contraction, making it a very
promising therapy for cardiac regeneration in humans. Two other studies further demonstrate
that there is a synergistic effect of the cotransplantation of adult cardiovascular progenitors with
epicardial cells that exceeds the effects of monotherapies (Smits & Riley, 2014).
b. Human Embryonic Stem Cells in Neural Regeneration
i.

Multiple Sclerosis

Multiple sclerosis (MS) is disease of the central nervous system, where some of its functions are
inhibited. In MS, the immune system attacks the myelin that covers nerve fibers and inhibits the
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interaction between the brain and the rest of the body. Current treatment for MS includes
corticosteroids to reduce nerve inflammation, and plasma exchange to reduce symptoms, among
others. These are very effective in lowering the frequency of relapses, although, are limited due
to their incapability to make up for the axon damage and hindering the disease progression
(Shroff, 2018).
hESCs have been found to serve as a source of neural cells for transplantation in neurological
disorders such as MS due to their pluripotent and self-renewing abilities (Shroff, 2018). Many
different studies have shown the actions of hESC derived neural progenitors in
immunomodulation and neuroprotection.
In a study done by Al Jumah et al. transplantation of hESC-OPs (oligodendroglial progenitors
derived from hESCs) in mice with experimental autoimmune encephalomyelitis (EAE), an
animal model for MS, led to an overall improvement of the disease symptoms. The EAE mice
displayed an improvement in neurological disability scores compared to that of control animals
at day 15 of treatment. Histopathologically, the transplantation of hESC-OPs decreased
inflammatory cells and gave rise to many T cells (immune response cells) in the spinal cord.
These results showed that transplantation of hESC-OPs can alter the pathogenesis of EAE (or
MS in humans) through immunomodulation (Al Jumah et al. 2012).
A study done by Aharonowiz et al. showed that hESC derived neural precursors (NP) were
transplanted into the brain ventricles of mice with EAE showed significantly reduced clinical
characteristics of EAE. Histopathologically, NPs differentiated to mature oligodendrocytes
which led remyelination in the brain. The study found that transplantation of hESC derived
neural precursors (NP) led to an overall reduction of the CNS inflammation and tissue injury,
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which was correlated with the reduction of both axonal damage and demyelination (Aharonowiz
et al., 2008). hESCs, therefore, may represent the ideal cell type for neural cell replacement.
hESCs have shown to be more successful in treatment of MS than other treatment options, such
as adult bone marrow transplant. Wang et al. compared eight lines of adult bone marrow stem
cells to four lines of hESCs, and found that all of the adult bone marrow stem cells expressed a
significantly higher level of inflammatory cytokines (stimulates autoimmunity and can worsen
MS) than the hESCs (Wang et al., 2014). Overall, hESCs have been shown to be a possible more
effective and safe treatment plan than the current options for MS.
ii.

Spinal Cord Injury

Cervical spinal cord injury (SCI) is characterized by the permanent complete or partial loss of
sensory and motor functions and many other complications. The injury leads to degeneration of
axons and causes death of neurons and oligodendrocytes, which causes demyelination of axons
and disrupts action potentials. This leads to impaired locomotion inpatients. Current treatments
are palliative, and include steroids, physiotherapies, and surgical interventions. The use of hESCs
are a very attractive treatment option because of their pluripotent nature. The transplantation of
the hESCs replace the lost cells and support overall recovery from the condition. SCI is an
important research focus for regenerative medicine given the current lack of treatment options
(Sharp et al. 2010). hESC-derived oligodendrocyte progenitor cells 1 (AST-OPC1)
transplantation in a rat model of cervical SCI has clinically shown a significant improvement in
locomotor performance when administered directly into the cervical spinal cord one week after
injury (Sharp et al. 2010). In February 2014, AST-OPC1 attained an Orphan Drug Designation
from the FDA for the treatment of acute spinal cord injury. These Orphan Drug Designations are
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ascribed to drugs that treat conditions affecting fewer than 200,000 people in the U.S. and is
given to clinically proven drugs.
As one of the first human trials on the use of hESC-derived OPCs in patients with acute SCI,
Geeta Shroff and colleagues treated patients with hESCs via IV in different phases over the
course of 4-6 months, allowing the hESCs to grow, repair, and regenerate the affected injury
region. They found that all patients showed significant improvement in overall health and
symptoms—ultimately showing how hESCs can be used as a safe and effective treatment plan
for SCI patients (Shroff, 2018). These promising clinical research results provide a framework
for future treatment of spinal cord injury.
iii.

Parkinson’s Disease

Parkinson’s disease (PD) is a neurodegenerative disease characterized by the loss of
dopaminergic neurons in the substantia nigra , with symptoms such as bradykinesia and rigidity.
The current treatment option for PD is administration of L-dihydroxyphenyl alanine
(L-DOPA). This is an effective treatment option in managing the symptoms of PD, however, LDOPA is associated with side effects that complicate its long-term use (Pham, 2017). hESC
therapy may be a useful alternative for improving PD symptoms. Current research on hESC
derived renewable midbrain progenitors shows promising results.
Midbrain dopaminergic (mDA) neuronal progenitors (NPs) arise during early development.
These mDA NPs migrate to their final destinations and develop into mature mDA neurons in the
substantia nigra. Chung et al isolated mDA NPs from hESCs and transplanted them into 6OHDA lesioned rats (an animal model of PD). They found that mDA NPs differentiated into
mDA neurons and produced integrated DA grafts—resulting in great developments in motor
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dysfunctions without the formation of tumors (Sangmi Chung et al., 2011). This can be used as
an effective treatment option in PD patients in the future.
c. Human Embryonic Stem Cells in Retina Regeneration
As a leading cause of severe visual impairment in the developed world, age-related macular
degeneration (AMD) affects 10 – 20% of people older than 65 years (Pan et al., 2013). Macular
degeneration of the retina causes loss in the field of vision and is to some extent shown to
successfully be treated with hESC-based therapy (Liu et al. 2018). There are currently nine
clinical trials with hESC derived retinal pigment epithelial cells (RPE) that are investigating the
benefits and adverse effects of the transplanted hESC-RPE cells (Liu et al. 2018). As of 2021,
studies show that hESC-derived RPE cells ameliorate the macular degeneration of the retina
temporarily (Lui et al. 2018). These studies provide promising early results related to the use of
transplanted hESC-RPE cells to alleviate macular degeneration of the retina.

C. Human Embryonic Stem Cells in Diabetes Mellitus
In type I diabetes, autoimmunity leads to a loss of β cells in the pancreas (produce insulin to
regulate blood sugar) and thus an impairment in blood glucose control. The current treatment of
insulin injections is undoubtedly effective, however, the daily glucose fluctuations lead to many
complications in the patient such as, kidney disease, blindness, and lower limb amputation
(Agulnick et al., 2015).
From 2010 to 2020, there has been significant advancements in reviving pancreatic development
with hESCs in vitro. Pancreatic endoderm cells (PECs) differentiated from hESCs were
transplanted into immunodeficient mice and were found to form functional pancreatic β cells.
However, this approach does have a limitation in which immune suppression occurs when
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treating patients with type I diabetes with allogeneic hESC‐derived pancreatic cells. Recently, a
research study found an approach to encapsulate the cell treatment via a planar
microencapsulation device containing a semipermeable barrier that is loaded with the hESC‐
derived pancreatic cells and implanted subcutaneously (Agulnick et al., 2015). This study
showed how highly purified endocrine cells differentiated in vitro from hESCs can effectively
produce functional β‐like cells.

D. Future Improvement Areas for Human Embryonic Stem Cells
hESCs have shown to be a promising tool for future therapies and treatments for an array of
diseases and conditions. However, there are some limitations in which must be improved for
better results and therapeutics. One challenge is that many cell types are difficult to produce and
only about ten cell types thus far are truly equivalent to normal human cells. Thus, better
methods and techniques must be created in order to diversify the functions and capabilities of
hESCs in medical applications. Furthermore, the funding of hESC research is also limited due to
the controversy revolving the ethic of hESCs. Nonetheless, hESCs have proven their value and
are expected to be pivotal for future advancements in the scientific and medical field.
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IV.

Ethical/Philosophical Perspective

A. The Ethics of Destroying Human Embryos for Research Overview
Despite the tremendous therapeutic promise of hESC research, it is met with a controversial
ethical debate due to its involvement with the destruction of the human embryo. The central
argument revolves around the question of whether or not preimplantation ex utero human
embryos should be accorded equal moral status to fully developed humans (Holland, 2012).
Some argue that human embryos have little to no moral status because they lack characteristics,
such as sentience or ability to feel pain and the benefit of utilizing the human embryos outweighs
the consequences.
Others argue that it is immoral to kill innocent humans and since human embryos are humans, it
is immoral to destroy them (Holland, 2012). Either way, there is a central agreement that human
embryos utilized in research should be treated with the utmost respect and that there should be
specific limits to what is allowed to be done with a human embryo.

B. When Does a Human Being Begin to Exist?
The controversy surrounding hESC research involves the belief that human embryos are human
beings (Holland, 2012). The general view of those who oppose hESC research is that a human
being begins to exist with the rise of the zygote at fertilization, where they are said to be “whole
living member[s] of the species homo sapiens possessing the epigenetic primordia for selfdirected growth into adulthood, with their determinateness and identity fully intact” (George and
Gomez-Lobo 2002, 258). This argument is opposed by others claiming that human beings do not
begin until after 14-days when twinning cannot take place.
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There are other contentions regarding the rejection that the early human embryo is a human
being. This claim is that human embryos are on their way to becoming, but are not yet human
beings. According to one view, the cells that make up the early embryo are simply an
accumulation of homogeneous cells in the same membrane but do not actually describe a human
being because of the cell's lack of coordinated function in preserving a life (Smith and Brogaard
2003). Each cell is alive but only become a part of a human being when there is cell
differentiation and communication that ensues 16 days after fertilization. Thus, based on this
assertion, using the 5-day human embryo to derive hESC lines for research does not entail the
destruction of human life.
This view is contrasted by others claiming that the human embryo, from fertilization onward,
develops in a single human organism by an intrinsic directed process. There is some intercellular
interaction in the zygote because in order for the development of the early embryo to occur, the
trophoblasts and ICM must form. Without coordination between the cells, all of the cells would
not differentiate in a similar direction (Damschen, Gomez-Lobo, and Schonecker, 2006). This
means that the embryo has the same nature, it is a whole human organism, from fertilization
onward; there is only a difference in the extent of maturation between the stages in the
development of the human being. The question remains what degree of cellular coordination and
maturation is sufficient to be considered an early human embryo and a human being.

C. The Moral Status of Human Embryos
Those that argue that a 5-day human embryo is a human being claim that the embryo has a right
to not be killed. This claim assumes that human beings have the same moral status as all stages
of their lives, beginning from the embryo. Others agree that a 5-day human embryo is a human
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being, but believe that they do not have the same right to life human beings do (George and Lee,
2009). This brings the question regarding the capacities that are necessary for the right to life.
Some argue that these capacities include consciousness and other mental functions: the basic
natural capacities that require the internal development in the organism before it can become a
being. They claim that day 5 human embryos lack these intrinsic capacities and thus do not have
the right to life.
Others claim that the difference between a being that deserves full moral esteem and a being that
does not, should not consist only of the fact that one has more capacities than the other (George
and Lee, 2009). Human embryos have a logical nature that is not fully portrayed until individuals
can reason. Because of the large range of mental and developmental capacities present in
embryos, infants, children, and adults, it is argued that one cannot justify treating some of these
individuals with moral respect while denying it to others (George and Lee, 2009).
Some counter this claim by saying that an entity that has the potential to reason does not entail
that it has the same moral status as a human being who can reason. If the reasoning behind
protecting embryos is the ability to become intellectual human beings, then some argue that this
moral status must also be ascribed to the trillions of somatic stem cells used in research today
that have the potential to reason with the help of outside interventions (Sagan and Singer 2007).
A response to this argument is the claim that human embryos have the potential to have an
“active disposition” and to develop into a mature human being, a trait that somatic stem cells do
not have, and their right of life should be respected and acknowledged (George and Lee, 2009).
Regardless of the different claims and arguments, most, if not all groups, believe that human
embryos possess an intrinsic value that calls for a measure of respect and deserves some moral
constraints on their misuse
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D. The Case of “Doomed “Embryos”
When excess embryos remain after IVF treatment, this individual has the option of storing them
for their future use, donating them to other infertile couples, donating them to research, or
discarding them. Some claim that it is moral to utilize the ‘surplus’ embryos which are destined
to be discarded, hence ‘doomed,’ in hESC research. This claim takes two forms. One is that
researchers who derive hESCs from embryos that were destined for destruction do not cause
their death, it just causes the manner of their death (Green, 2002). Another is that it is moral to
destroy an embryo set for discard if that embryo is used for the further benefit of others (Curzer,
2004). There are two counter-arguments to these claims.
First, if the research donation option was not available, couples could choose to donate the
embryos to other infertile couples instead of discarding them. Second, a researcher’s ability to
prevent the destruction of the received embryos raises issues for the argument that the decision to
discard the embryos causes their destruction (Curzer, 2004).
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V.

Sociocultural Perspective

A. Religious and Cultural Traditions
Religious beliefs are an important determining factor for people’s worldview and social
existence—these beliefs even affect their decisions about medical and scientific issues that have
moral implications. This section aims to better understand the stances of different faiths on hESC
research and the reasoning behind them.
a. Judaism
There are four main points that contribute to the Jewish ethical discourse: the status of the
embryo, the duty to save lives, the duty to be guardians of the world, and emphasis on
knowledge.
In the Jewish tradition, an embryo’s moral status is ascribed after the 40 day period—thus at the
time of fertilization the human embryo does not constitute a moral status. During the first 40
days from fertilization, until the completion of organogenesis, the human embryo is defined as
“plain water.” Human embryonic stem cell research is generally permissible in Jewish traditions
only when the embryo is from the surplus, ‘doomed’ embryos (Walters, 2004). Thus, it is
prohibited to create an embryo for the single purpose of research. It is a “mitzvah” to use the
surplus embryos for research, according to Rabbi Elliot Dorff, professor of philosophy at the
University of Judaism in Los Angeles. “It’s not only permitted, there is a Jewish mandate to do
so,” Dorff said (Lui, 2020).
In the Jewish cultural and religious traditions, there is an enormous emphasis on saving lives.
According to Jewish principles, ‘saving life supersedes all other duties,’ therefore great value is
placed in medical research for alleviating pain and suffering. Some conservative Jewish scholars
have utilized this for reasoning in support of the hESC research. For example, rabbi Moshe
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Tendler, professor of Jewish Medical Ethics at Yeshiva University in New York and one of the
leading medical ethicists in the United States during the beginning of the hESC research debate,
called it “the hope of mankind.” Tendler continues, “the only hope we have of understanding
what’s going on in the whole field of oncology now resides in the human embryonic stem cell
research (Walters, 2004).” Furthermore, The Women’s Zionist Organization of America and the
National Council of Jewish Women are both in favor of hESC research. As per pikuach nefesh,
duty to save life, one is obliged to heal and obliged to save, even if one is to break the laws of
Shabbat (Lui, 2020).
Jews see themselves as guardians of the world in a world that seems to be left deliberately
incomplete. Jews take it as their own task and duty to complete God’s creation in the unfinished
world. Changing and shaping God’s creation is the completion of order. Thus, upon this point,
Jews are even encouraged to support the utilization of hESCs in life changing research (Lui,
2020).
Jews are seen as readers and knowledge seekers of the natural world. The ability to interpret
many complicated and multifaceted texts is the work of being a reader and studier of the natural
world. Seeking knowledge is a very important aspect of the Jewish tradition—thus learning,
studying, and researching is the task of a Jewish person (Lui, 2020). Some Jewish scholars use
this point as reasoning for their support of hESC research.

b. Islam
More than a religion, Islam is an all-encompassing way of life, regulated through its law (fiqh).
Seeking Islamic law in Islamic bioethical discourses is prevalent in the Muslim community
worldwide. Medical treatment and activity are bound by Islamic law and it is therefore required
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that a Muslim in the field of medicine and research to understand the Islamic legal evaluation of
bioethical discourses such as hESCs. The Islamic legal ruling is founded through scholars of fiqh
from many sources of Islamic law (Quran, Sunnah, etc). The Prophet’s (PBUH1) statement that
Allah (God) has not created any illnesses without its cure, further implies the obligation of
Muslims to seek medical treatment and search for available cures (Sahih al- Bukhari). Thus,
historically, Islamic tradition in medicine and medical treatment has been prevalent and rich.
Islamic scholars asses the status of the human embryo based upon “the breathing into it of the
soul,” also known as ensoulment. There are differences in the interpretation of the Islamic
sources and therefore, scholars are separated based on three interpretations—ensoulment takes
place either forty, forty-two, or 120 days after conception.
Each one of you possesses his own formation within his mother’s womb, first as a drop
of matter for forty days, then as a blood clot for forty days, then as a blob for forty days,
and then the angel is sent to breathe life into him (Sahih al-Bukhari [d. 870] and Sahih alMuslim [d. 875].
After ensoulment, this human embryo is without a doubt a human being and is characterized as
having acquired specific rights through Islamic law. hESCs are cells derived from five day
human embryos, and thus, do not have a moral status according to Islamic law. Most scholars
within the Islamic Fiqh Academy (creators of the Islamic law) have therefore accepted hESC
research involving these five day old blastocytes. This is with the condition that the hESCs are
not misused and are not harvested from embryos created solely for the purpose of research. In its
2003 declaration on hESCs, the Islamic Fiqh Academy condoned the use of surplus IVF embryos
for harvesting hESCs with the parents’ consent (Bouzenita, 2017).

1

PBUH—Peace Be Upon Him—is a phrase that is said after the mentioning of the Prophet.
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Some Muslim scholars argue that an embryo on a petri dish does not have the status of a
complete human being, but can still be legally considered to having the ability to potentially
develop into a human being. Among other evidence, these Muslim scholars support their stance
on hESCs by recounting the Prophet’s PBUH prohibition of eating (thus destroying) ostrich eggs
while in the state of iḥrām (status of a pilgrim during visiting holy sites) (Sahih al- Bukhari).
Many scholars argue that this is because the ostrich egg had the potential to develop into
ostriches. With this reasoning, these scholars argue that these embryos must be treated with
dignity and respect as they do have to potential to develop into human beings (Bouzenita, 2017).
A major moral imperative in Islam is the prevention of human suffering and illness in ways that
are possible. Prophet Muhammad PBUH said:
Whoever relieves a believer’s distress of the distressful aspects of this world, Allah will
rescue him from a difficulty of the difficulties of the Hereafter. Whoever alleviates [the
situation of] one in dire straits who cannot repay his debt, Allah will alleviate his in both this
world and in the Hereafter (Sahih al- Bukhari).
It is an obligation of the Muslim person to alleviate pain and suffering of a human being. Some
scholars in the Muslim community utilize this in their argument to support hESC research, as it
seeks to alleviate the pain and suffering of human beings.
The very first verse revealed in the Quran urges Muslims to seek knowledge. Prophet
Mohammed PBUH reiterated this sentiment, saying “to seek sacred knowledge is an obligation
on every Muslim” (Sahih al- Bukhari). Thus, striving in seeking knowledge is among the most
important duties for every individual. Some Muslim scholars have used this as further support
for hESC research.
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c. Christianity
i. Roman Catholicism
Throughout history, the Roman Catholic beliefs about the moral status of the early human
embryo has been studied intensely. Catholic scholars acknowledge when an embryo becomes a
human being is unknown but also argue that the soul is present from conception. Thus, as it
comes to hESC research, Catholic leaders and scholars do not support it by the account that
hESC research inflicts harm on the embryo’s soul. Catholic leaders believe that although hESC
research may haves some benefits towards society, these benefit do not supersede the amount of
harm done to human embryos during hESC research—advocating the principle “the ends do not
justify the means” (Sivaraman, 2019).
Furthermore, unlike Judaism and Islam, Roman Catholicism opposes the use of surplus embryos
from IVF treatments in hESC research because it “still entails a proximate material cooperation
in the production and manipulation of human embryos on the part of those producing or
supplying them” (Sivaraman, 2019). Some scholars have opposing views and thus support hESC
research, such as Father Norman Ford, a Roman Catholic theology professor at Salesian
Theological College in Australia. Ford argues that genetic uniqueness does not make a zygote a
human individual, and further provided reasoning for his stance by using the ability of the zygote
to undergo twinning as evidence that it lacks developmental individuality and thus cannot yet
qualify as a human being (Walters, 2004).
ii. Eastern Orthodoxy
Eastern Orthodox leaders and scholars hold a very similar viewpoint as the Roman Catholic
leaders as it involves hESC research. The Eastern Orthodox tradition opposes hESC research on
the basis of the belief that the process towards true human development starts with the zygote.
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This zygote is devoted to a developmental path that will lead to a potential human being.
Orthodox Christians confirm that the sacredness of human life is at all stages of development —
from conception to birth and death (Walters, 2004). They believe that the zygote is merely an
human yet to be born and is entitled to the same rights as those already born. In the case of
surplus embryos, Eastern Orthodox traditions oppose its use in hESC research due to its beliefs
that human life begins at conception, similar to Catholic beliefs.
iii. Protestant
Protestant leaders and scholars are divided when it comes to the support or opposition of hESC
research. Their views are multi-dimensional and thus there is no explicit policy as of current.
Some Protestants oppose hESC research based on the belief that hESC research kills that human
being—the five-day embryo is considered to have human rights (Neaves, 2017). These who
oppose hESC research cite Jeremiah 1:5 as evidence for their stance:
Before I formed you in the womb I knew you, and before you were born I consecrated
you; I appointed you a prophet to the nations (The Holy Bible, Revised Standard Version,
1952).
Some Protestants leaders support hESC research on the basis that blastocysts do not entail
personhood and due to their lack of individuality—twinning does not occur until after blastocyte
stage. These leaders cite Ecclesiastes 11:5 as evidence for their support for hESC research:
As you do not know how the spirit comes to the bones in the womb of a woman with
child, so you do not know the work of God who makes everything (The Holy Bible,
Revised Standard Version, 1952; Dudley, 2011).
These scholars believe that this biblical verse implies the pre requisite of bone formation for
ensoulment to be characterized in an embryo (Neaves, 2017).
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Oppose hESC Research Support hESC Research
Lutheran Church-Missouri Synod
National Association of Evangelicals
Southern Baptist Convention
Assemblies of God
The Reformed Church in America

Presbyterian Church (U.S.A.)
Unitarian Universalist Association of Congregations
United Church of Christ
United Methodist Church
Episcopal Church

Table 1. Categorization of the different stances (Oppose/Support hESC Research) of different
Protestant faiths.

d. Buddhism
Buddhism places importance on the principle of ahimsa, non-harming. Buddhists have
reservations on the destruction of life, which is believed to generate bad karma. The question
becomes does hESC research inflict any harm and when does a stem cell become a human? The
Dalai Lama discusses this point by stating:
But how do we understand at what point consciousness enters the embryo? This is
problematic. A fetus, which is becoming a human is already a sentient being. But a
fertilized egg may actually bifurcate into 8, 16, 32, 64 cells and become an embryo, and
yet be naturally aborted and never become a human being. This is why I feel that for the
formation of life, for something to actually become a human, something more is needed
than simply a fertilized egg (Dalai Lama, 2003).
Most Buddhist take the stance that hESC research does not inflict harm because the embryo has
yet to feel pain and have conciseness.
The majority of Buddhist leaders and scholars are in support of hESC research. Most believe that
it is only permitted if the intention of the research is to find human therapeutics to prevent
suffering from illness. In other words, if the intent of hESC research is to benefit humankind, it is
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supported. They also believe that a five day embryo used in hESC research does not violate the
‘do no harm’ principle because they believe that life only begins when there is a sense of
consciousness and pain. The majority of Buddhists are also supportive of utilizing surplus
embryos in hESC research—arguing that it is better to use the surplus embryos for a good cause
to save lives rather than discard them. Very few Buddhists oppose hESC research and believe
that the five day embryo has life and is a being that is harmed in the process of hESC research
(Neaves, 2017; Sivaraman, 2019).

e. Hinduism
The religion of Hinduism is largely guided by the principle of ahimsa, non-harming, similar to
the religion of Buddhism. Hindus believe that inflicting any kind of harm to any soul or being
creates bad karma. Some Hindu leaders and scholars believe that a five day embryo, in the case
of hESC research, does not experience pain because the body is not fully forms for the soul to
dwell on. In other words, it is the soul that experiences pain and pleasures, and since a five day
embryo does not constitute having a soul, hESC research does not inflict harm on a life. Other
Hindu leaders view the beginning of personhood overlaps with reincarnation at the moment of
conception, and that the earliest human embryo deserves respect. In this respect, these Hindu
leaders oppose hESC research as a five day embryo constitutes life and thus would be harmed—
creating bad karma and breaking the principle of ahimsa (Neaves, 2017). The majority of Hindus
are also supportive of utilizing surplus embryos in hESC research as it is better to use them for
research purposes to save lives rather than discarding them. Using these surplus embryos for
research is in line with the principle of dana, donating excess material for a good cause, in the
Hindu tradition (Sivaraman, 2019; Walters, 2004).
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B. hESC Research Policies Around the World—Possible Correlations between Religious
Traditions and National or Cultural Views
This section will aim to provide a clear understanding of the hESC research policies in the many
different nations worldwide. This is important for the understanding of each nation’s alignment
between their religious, cultural, and political views on hESC research. Each region was chosen
based on the amount of valid and credible sources available involving each nation’s policy on
hESC research. Different attributes of a nation play different roles in affecting their overall views
on hESC research. Among these attributes, religious and cultural traditions weigh most heavily
when a country decides the moral status of the embryo and thus whether or not to support hESC
research. Based on the findings in this sections, case studies will be done on countries with a
discord in their hESC research policies and their religious/cultural ideas.

a. Asia

Figure 1. Map of Asian countries categorized by their policies on hESC research.
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i.

China

Due to a rise in interest in hESC research, the People’s Republic of China Ministry of Science,
Technology, and Health issued official ethical guidelines and policies regarding hESC research.
These policies state that it is required that the embryos utilized for hESC research only come
from:
(1) Donated human embryos,
(2) donated germ cells,
(3) blastocytes obtained from somatic cell nuclear transfer technology, or
(4) spared blastocytes from in vitro fertilization (IVF) procedures
(Ministry of Science and Technology and Ministry of Health, 2003)
China has one of the most unrestrictive policies on hESC research in the world. This mainly
stems from the cultural and national attitude towards hESC research, where the general
population is in support of the Buddhist view on the moral status of the human embryo. Most
Chinese citizens view the human embryo as not having any inherent moral value and that a
human begins with birth, therefore in support of hESC research.
ii.

India

India’s main religion is Hinduism, practiced by almost 80% of their population. Thus, most of
the policies and regulations are created with the perspective of the Hindu religion. The hESC
research policy in India is aligned with the Hindu view on the matter. The policy states that early
human embryos (up to 14 days after fertilization) are to be utilized in research when attained
from IVF clinics as surplus embryos and that no embryo can be created for the sole purpose of
obtaining hESCs (Indian Council of Medical Research & Department of Biotechnology, 2017).
This policy is permissive of hESC research, in similarity to the Hindu viewpoint that the early
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human embryo does not constitute a moral status, and thus, hESC research does not inflict harm
on a life (Shekhar Tiwari & Desai, 2011).
iii.

Taiwan

The hESC research policy in Taiwan states that embryos for research purposes only be obtained
from:
(1) Abortions,
(2) embryos remaining from IVF procedures, or
(3) Embryos produced by somatic cell nuclear transfer without the presence of primitive
streaks.
(Human Embryo and Embryonic Stem Cell Act, 2011)
It also states that hESC research shall not use IVF to produce embryos for the sole purpose of
research. This policy is in general support of hESC research, which stems from Taiwan’s cultural
view on the moral status of the embryo. About 80% of Taiwan’s population practices Buddhism,
which shows a general support for hESC research based on the belief that the human embryo is
yet to have a soul and thus does not constitute an inherent moral status (Chen et al., 2017).
iv.

Japan

Japan’s policy on hESC research states that a human embryo used for derivation of hESCs shall:
(1) Be the human fertilized embryo which has initially been created for the purposes of
fertility treatment (i.e. via IVF treatment), but is planned not to be used any longer for the
purposes, and is intended to be discarded by its donors, and
(2) be used within 14 days after the fertilization, not counting any time during which it has
been stored frozen.
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In Japan, the law on hESC research also contains a requirement for approval from a
governmental body (Ministry of Education, Culture, Sports, Science and Technology, 2009).
Shinto and Buddhism are Japan's two major religions, both of which mainly support the idea of
hESC research based on the belief that the early human embryo lacks a moral status.

b. Oceania

Figure 2. Map of Oceanic countries categorized by their policies on hESC research.
i.

Australia

Australia’s policies on hESC research state that in order to conduct hESC research, one must
apply to the NHMRC Licensing Committee for a license authorizing one or more of the
following:
(1) Use of excess IVF embryos,
(2) creation of human embryos using precursor cells from a human embryo or a human fetus,
and use of such embryos, and
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(3) research and training involving the fertilization of a human egg by a human sperm up to,
but not including, the first mitotic division, outside the body of a woman for the purposes
of research or training.
The policies on hESC research in Australia are strict, but still supportive under certain conditions
(Human Embryos Act, 2016). Christianity is currently the most dominant religion in Australia,
however, the hESC policies do not align with the general Christian viewpoint on hESC research,
which is not in support of hESC research in any form. This inconsistency may be due to the high
religious diversity and the fastest growing religious affiliation in Australia being ‘no religion’,
with over 30% of the population in this category. The high degree of religious diversity in
Australia fosters a multidimensional culture in which laws may be more based upon the societal
moral values and ethics.

c. Europe
Figure 3. Map of European countries categorized by their policies on hESC research.
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i.

Germany

Germany has one of the most restrictive policies for hESC research, due partly to the history of
the immoral medical experiments done by the Nazi regime during WWII. For example, the
creation of hESCs is prohibited under any circumstance by the Embryo Protection Act. This
banned the creation of hESCs from surplus embryos created for IVF and embryos created for
nonreproductive purposes, eliminating all potential embryo sources for research (Embryo
Protection Act 1990, amended 2011). However, in 2008, the German government created a law
that approved the use of imported hESC lines created before May 1, 2007, to better assist the
study of stem cell therapy. The German law on this states:
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“The importation and utilization of embryonic stem cells for research purposes shall be
permissible under the conditions stipulated in section 6 if
a. the competent agency has satisfied itself that
(1) the embryonic stem cells were derived before May 2007 in the country of origin in
accordance with relevant national legislation there and are kept in culture or are subsequently
stored using cryopreservation methods (embryonic stem cell line),
(2) the embryos from which they were derived have been produced by medically-assisted in vitro
fertilization in order to induce pregnancy and were definitely no longer used for this purpose and
that there is no evidence that this was due to reasons inherent in the embryos themselves,
(3) no compensation or other benefit in money’s worth has been granted or promised for the
donation of embryos for the purpose of stem cell derivation and if
b. other legal provisions, in particular those of the German Embryo Protection Act , do
not conflict with the importation or utilization of embryonic stem cells (Stem Cell Act 2002,
amended 2017).”
Furthermore, the policy specifically states that research involving hESCs should be:
(1) eminent research that aims to generate medical knowledge for the development of
therapies in human disease,
(2) that the questions to be studied in the research have been studied as far as possible
through in vitro models, and
(3) the questions to be studied cannot be studied by using cells other than hESCs
(Stem Cell Act 2002, amended 2017).
The main religion practiced in Germany is Christianity, with around two-thirds of the population
identifying as Christian. The very restrictive nature of Germany’s hESC research policies may
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also be due to the general Christian view of the human embryo—inherent abilities to develop
into a human being, and thus an entity with moral value.
ii.

Italy

Italy has restrictive laws on hESC research similar to Germany. Article 13, section nine states
that:
(1) the production of human embryos for research purposes is prohibited,
(2) research on any human embryo is prohibited, and
(3) research on any human embryo is only permissible if aimed to preserve the health and
development of the same embryo and when other options are not available.
(Rules on medically assisted procreation, 2004)
The policy does not, however, explicitly forbid researchers from using existing hESC lines that
have been imported from other countries. The strict nature around hESC research in Italy can be
partly attributed to the religious nature of the nation, where the Vatican City is located and most
practice Roman Catholicism. The general consensus in regards to hESC research for Catholicism
is in opposition to the matter due to the belief that the human embryo has a moral status, and thus
inflicting harm on the embryo is prohibited.
iii.

Russia

In 2002, Russia prohibited all stem cell research, including those with imported hESC lines.
With recent advancements in the stem cell field, Russia approved a regulatory framework for
stem cell research in 2016 by creating a Biomedical Cell Products Law. However, the law still
specifically prohibits hESC research, stating:
(1) The inadmissibility of creating a human embryo for the production of biomedical cell
products;
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(2) the inadmissibility of using biological material obtained by suspension or interruption
of the development of a human embryo or fetus for the development, production and use
of biomedical cell products.
The strict prohibition of hESC research in Russia can be mostly attributed to the Russian
Orthodox Church’s opposition to any research involving the human embryo. The Russian
Orthodox Church believes the human life begins at conception or with the fertilization of a cell.
However, there are still some inconsistencies between Russian society and the Russian Orthodox
Church. For example, Russia permits abortions during the first 12 weeks of pregnancy for any
reason. An abortion ends the development of the human embryo just as hESC research does—
thus, Russian Law does not fully align with the principles of the Russian Orthodox Church.
iv.

United Kingdom

The United Kingdom’s policy on hESC research was originally created in 1990 and thereafter
amended in 2008—namely the Human Fertilization and Embryology Act. This law states that:
(1) An embryo’s fertilization is not complete until the appearance of the primitive streak,
(2) utilization of an a human embryo in research is permitted,
(3) donor of the embryo (such as surplus embryo from IVF therapy) must consent to the
utilization of the embryo in scientific and medical research.
The United Kingdom is mostly composed of Protestants and Anglicans. The main Christian
viewpoint towards using human embryos for research is in opposition of the field because of the
belief that human embryos have a moral status and should not be harmed for any purposes. The
English laws involving hESC research are in general support of the field, and thus do not align
with the Christian stance on hESC research. This may be due in part to the split nature of the
Protestant faith in their support for hESC research
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v.

Spain

Spain has a permissive policy in regards to hESC research per the Biomedical Research Law.
This law states that:
(1) Research with the embryos must have the consent of the donors,
(2) the donors of the embryo shall be fully informed of the techniques that are going to be
applied to the embryo
(3) the creation of the human embryos for the sole purpose of research is strictly
prohibited
(4) the use of any technique for obtaining hESCs for therapeutic and research purposes is
permitted when it is from consented donors of surplus IVF embryos.
(Biomedical Research Law 2007, amended 2011)
The majority of the population in Spain (68%) practices Roman Catholicism. The general
Catholic view on hESC research is in opposition to the field due to the belief that the human
embryo has a moral status and thus no harm should be afflicted upon them. However, Spanish
policy is in support of hESC research and thus the use of early embryos (up to 14 days after
fertilization) for the production of stem cell therapies. Thus, the laws of Spain do not specifically
align with the Roman Catholic Church’s stances on certain issues.
vi.

France

The Act of Bioethics passed in 2011 in France supports the utilization of surplus IVF embryos
for hESC research. The conditions to be met for hESC research are as follows:
(1) Research project must be scientifically important
(2) research is likely to lead to a major medical breakthrough
(3) hESC research abides by the ethical principles involving human embryos
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(4) donors consent for the utilization of the embryo must be established
The major religion in France is Christianity; France’s policy in support of hESC research does
not align with the Christian viewpoint on the human embryo’s role in research.

d. Arabia and Africa

Figure 4. Map of African countries categorized by their policies on hESC research.
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Figure 5. Map of Arabian Peninsula countries categorized by their policies on hESC research.

i.

Turkey

Turkey's law for assisted reproduction technology (Regulation on Assisted Reproductive
Treatment Practices and Assisted Reproductive Treatment Centers) prohibits the creation and
storage of human embryos for nonreproductive purposes. Turkey banned human embryo
research, the derivation of hESC lines, and the donation of surplus embryos from IVF treatment
to be used for biomedical research (Ozturk, 2017).
Turkey’s largest religion is Islam, where 99% of the population is registered as Muslim. Most
Muslim scholars believe that in an early 5-day embryo, ensoulment has yet to take place, and
thus the embryo does not constitute having a moral status. Therefore, it is generally accepted in
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Islam to utilize the ‘doomed’ surplus embryos for hESC research. Though Turkey has a Muslim
majority, its constitution enshrines secular values. With regards to hESC research, Turkey
prohibits the derivation of hESC lines from human embryos, including surplus IVF embryos.
This is in contradiction to the general Islamic support for hESC research using surplus embryos
from IVF procedures.
ii.

Iran

In 2002, Iran revealed one of the most permissive stances among Muslims when its Supreme
Leader, Ayatollah Khamenei, publicly supported hESC research by creating the Stem Cell Fatwa
[law]. This law states that Iran permits the use of surplus embryos from IVF procedures for
hESC research purposes. Since then, Iranian researchers have created six lines of hESCs, one of
which registered to the International Society of Stem Cell Research (Kanyış, 2020).
In Iran, religion significantly influences the sociocultural, moral, legal and political discourses in
society. The discussion of bioethics and governance of hESC research is thus regulated by
religion. The religion of Iran is Islam; the Islamic principles align with the Iranian laws on hESC
research—both of which support the use of surplus IVF embryos for hESC research purposes.
iii.

Saudi Arabia

The 2003 Fatwa issued in Saudi Arabia by the Fiqh (Islamic Jurisprudence) Council of the
Muslim World League provides the religious framework for stem cell research in Saudi Arabia.
This legal decree states:
(1) It is permissible to obtain, grow, and use embryonic stem cells for therapeutic and
research purposes if obtained from embryos that have been miscarried or aborted for
therapeutic reasons allowed by the sharia (Islamic law), or deemed surplus embryos after
IVF procedure. One must also establish the permission of the embryo donors.
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(2) It is impermissible to obtain and use stem cells if taken from impermissible sources,
such as: embryos that are aborted willfully and without a medical reason permitted by
sharia, creation of an embryo for the sole purpose of research, or therapeutic cloning.
(Alahmad et al., 2020)
The religion of Saudi Arabia is Islam; Islamic faith allows the use of surplus 5-day embryos from
IVF treatments in hESC research. This is due to the belief that in an early 5-day embryo,
ensoulment has yet to take place, and thus the embryo does not constitute having a moral status.
The laws regarding hESC research in Saudi Arabia align with the Islamic stance on the matter.
iv.

Israel

Israeli law permits hECS research under some conditions:
(1) The creation of an embryo is not done for the sole purpose of research
(2) the creation of an embryo is permissible when there is potenatial to save human life
(3) ethically permissible to experiment with new in vitro technologies to produce ES cells
(4) surplus embryos from IVF treatments are permissible to use in hECS research with
the consent of the donors.
(Public Health Regulations, 1987)
The religion in Israel is Judaism; the Israeli policy regarding h ESC research aligns well with the
general stance of the Jewish faith on the matter. In the Jewish tradition, it is believed that an
embryo’s moral status is ascribed after the 40 day period—thus the 5-day embryo does not
constitute a moral status. Furthermore, the Jewish tradition states that it is one’s duty to utilize
the embryos to save lives. Thus, the support for hESC research in Israeli law can be partly
attributed to its support by the Jewish faith.
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v.

Tunisia

Tunisia has a strict policy on hESC research. According to Tunisian law:
(1) It is prohibited to created embryos for the sole purpose of research and
experimentation.
(2) Surplus embryos from IVF treatment are not be used in hESC research in any form.
(Tebourski et al. 2004)
The main religion in Tunisia is Islam—the constitution declares Islam is the country's religion,
but also declares to be a civil state and allow freedom of religion. This means that most policies
in the Tunisian government and society should align with the Islamic stance on certain issues.
However, there seems to be an inconsistency in this when it comes to hESC research as Tunisia
has a prohibitive policy on hESC research and the Islamic faith permits hESC research to a
degree and under certain conditions. Islamic faith allows the use of surplus 5-day embryos from
IVF treatments in hESC research. This is due to the belief that in an early 5-day embryo,
ensoulment has yet to take place, and thus the embryo does not constitute having a moral status.
Thus Tunisia’s prohibitive policy does not concur with the Islamic tradition on hESC research.
vi.

South Africa

South Africa has a permissible policy regarding hESC research. The law states that:
(1) Embryos (not more than 14 days old) can be used for the creation of hESCs under
ethical conditions
(2) Importation of human embryos for research purposes is permitted if approved by the
Minister
(3) Use of surplus embryos from IVF treatment is permitted for use in hESC research if
the donor’s consent is established.
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(Dhar, 2009)
The majority of the South African population practices Christianity (over 80%). The general
Christian view towards hESC research is in opposition to the matter due to the moral status
ascribed to the early embryo. Per Christian tradition, the embryo is inherently a human and no
harm should be afflicted upon it, and thus hESC research is prohibited. South African laws
involving hESC research are in general support of the field, and thus do not align with the
Christian stance on hESC research.

e. South America
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Figure 6. Map of South American nations categorized by their policies on hESC research
i.

Argentina

The public law involving hESC research in Argentina is vague and broad. The Argentinian
Ministry of Health issued MS610 in 2007, which states that “activities related to the use of
human cells for subsequent implantation in humans fall within the purview of the INCUCAI (El
Instituto Nacional Central Único Coordinador de Ablación e Implante)” (Dhar, 2009). This
formally recognizes INCUCAI's authority to oversee activities involving stem cells. The
resolution is very brief and does not specify which type of cell it applies to, nor to any specific
research procedures that are permitted. Ultimately, it is generally interpreted broadly to include
embryonic stem cells and its research.
The majority of Argentina’s population practices Christianity. The Christian faith rejects hESC
research of any kind due to the inherent moral status the human embryo has. Argentinian law on
hESC is vague and implies at least some support for the field, which is in contradiction to the
Christian stance on the issue. This is especially interesting as the current pope, Pope Francis, is
from Argentina and as the leader of the worldwide Catholic Church, he opposes hESC research.
ii.

Brazil

Brazilian law shows general support for hESC research. The law states:
(1) It is permitted to derive hESCs from IVF surplus human embryos for research
purposes provided three conditions are met
(i) embryo is unfeasible for use in IVF
(ii) embryo has been frozen for three years or more
(iii) consent for the donors is established
(Biosafety Law 2005, amended 2007).
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The majority of the population in Brazil practices Christianity—Brazil has the largest Roman
Catholic population in the world. Roman Catholicism condemns any research done with embryos
as it is believed that the human embryo is a human being with a soul present from the instant of
conception. However, Brazil’s policy supports hESC research and thus conflicts with the
Christian view on hESC scientific and medical research.
iii.

Peru

The law in Peru regarding hESC research is in accordance with the Christian views on the use of
human embryos for research purposes. The law states that
(1) The child and adolescent have the right to life from the moment of conception.
(2) A human embryo is guaranteed protection from research or experimentation from the
moment of conception.
(3) The creation of human embryos for purposes other than procreation is strictly
prohibited.
General Health Law (LAW No. 26842)
The predominant religion in Peru is Roman Catholicism, in which it is believed that the human
embryo is a human being with a soul present from the instant of conception. The Peruvian
prohibition of hESC research is in accordance with the belief of the Christian faith in hESC
research.
vi.

Costa Rica

The law in Costa Rica simply states that the manipulation of the embryo's genetic code, as well
as all forms of experimentation on it, are absolutely prohibited. Thus, hESC research of any
shape or form is prohibited in the nation of Costa Rica. Roman Catholic is the most common
religious affiliation in Costa Rica, in which it is believed that the human embryo acquires a
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moral status and thus protection from the moment of conception. The Costa Rican prohibition of
hESC research is in accordance with the belief of the Christian faith in hESC research.
f. North America
i.

Canada

Figure 7. Map of Canada and its permissive policy on hESC research
Per the Assisted Human Reproduction Act created in 2004, human embryo research is permitted:
(1) only on embryos created for IVF and donated for research
(2) the human embryo is 14 days or younger in its development
(3) the embryo is not created for the sole purpose of research.
The permissive type of Canada’s hESC research policy can be partly attributed to the secular
nature of the governance of the nation. Even though the majority of Canada’s population
practices Christianity, the nation sets a secular code of moral and ethical values that governs the
policies within the nation, which may be one reason for its support for hESC research.
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ii.

United States

Figure 8. Map of the US and the different hESC research policies per state.
The Dickey-Wicker amendment in 1996 prohibited the use of federal funds for the creation of a
human embryo or embryos for research purposes. In 2000, the NIH guidelines for hESC research
were created, stipulating that:
(1) hESCs must be derived with private funds from frozen embryos in fertility clinics;
(2) the embryo in use must be surplus embryo of the donor; and
(3) donor’s consent must be established.
(Human Embryonic Stem Cell Policy Under Former President Bush, 2001)
In 2001, the Bush administration limited federally funded hESC research to the use of a small
number of existing cell lines. Congressional bills that were to allowed the federal funding of
hESC research using surplus embryos from fertility clinics were vetoed by President Bush in
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2006 and 2007. The main premise for this position was to avoid “encouraging the
(presumptively) unethical act of embryo destruction and still advance the worthy cause of
medical research” (President’s Council on stem-cell Research, 2004). However, this policy
position was reversed by the Obama administration in 2009 with an executive order stating:
For the past 8 years, the authority of the Department of Health and Human Services,
including the National Institutes of Health (NIH), to fund and conduct human embryonic
stem-cell research has been limited by Presidential actions. The purpose of this order is to
remove these limitations on scientific inquiry, to expand NIH support for the exploration of
human stem-cell research, and in so doing to enhance the contribution of America's scientists
to important new discoveries and new therapies for the benefit of humankind (Obama, 2009).
In July of 2009, the most notable court case involving the government's funding of embryonic
stem cell research, was filed—Sherley v. Sebelius. James Sherley, M.D., Ph.D., filed a lawsuit
against the National Institutes of Health (NIH) and the Department of Health and Human
Services, arguing that they are in violation of the Dickey-Wicker amendment. In 2011, U.S.
district court for the district of Columbia ruled in favor of hESC research in Sherley v. Sebelius.
In 2016, President Obama signed the 21st Century Cures Act into federal law, which provides a
regulatory framework for medical therapies enabled by hESC research.
Although the United States is predominately comprised of Christians, whom generally oppose
hESC research, the nation’s federal policy is currently in support of the issue. This may be
attributed to the very secular nature of the United States, which was essentially founded upon the
principle of secularism. However, with that said, state laws regarding hESC research vary
widely, with some restricting their use, others permitting certain activities, and other strictly
prohibiting their use in research. Below, there is a deeper investigation of US states’ hESC
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policies adapted from the National Conference of State Legislatures. This is because the US
allows states to determine details not covered explicitly by federal law.
Table 1. State Legislative Examples Restricting or Banning Fetal Experimentation

State Description of Legislation
Florida Chapter 390.0111-(6) Experimentation on fetus prohibited; exception.— No

Indiana
Kentucky

North
Dakota

person shall use any live fetus or live, premature infant for any type of scientific,
research, laboratory, or other kind of experimentation either prior to or subsequent to any
termination of pregnancy procedure except as necessary to protect or preserve the life
and health of such fetus or premature infant.
16-34-2-6 (1993) Prohibits experiments (aside from pathological examinations) on an
aborted fetus. Also bars transporting a fetus across state lines for the purpose of
experimentation.
436.026 (1992) Prohibits experimentation on a "live or viable aborted child." Any person
who shall sell, transfer, distribute, or give away any live or viable aborted child or
permits such child to be used for any form of experimentation shall be guilty of a Class B
felony.
14-02.2-01 and 14-02.2-02 (1975 and 1989)—Prohibits experimenting on a "dead fetus
resulting from an occurrence other than an induced abortion" unless the woman has
consented. Prohibits the use of fetal organ or tissue from an abortion for any research,
experiment or study. Prohibits abortion for the purpose of transplantation,
experimentation, or research or study.
Prohibits experimenting or conducting research on a "live human embryo, fetus, or
neonate.” Allows research that does not harm the fetus as long as the women is not
planning on aborting the fetus.

Ohio 2919.14 Abortion trafficking.
(A) No person shall experiment upon or sell the product of human conception which is
aborted. Experiment does not include autopsies pursuant to
sections 313.13 and 2108.50 of the Revised Code.
(B) Whoever violates this section is guilty of abortion trafficking, a misdemeanor of the
first degree.

Oklahoma §63-1-735 Sale of child, unborn child or remains of child - Experiments.
Section 1-735. A. No person shall sell a child, an unborn child or the remains of a child
or an unborn child resulting from an abortion. No person shall experiment upon a child
or an unborn child resulting from an abortion or which is intended to be aborted unless
the experimentation is therapeutic to the child or unborn child.
B. No person shall experiment upon the remains of a child or an unborn child resulting
from an abortion. The term "experiment" does not include autopsies performed according
to law.
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South 34-23A-17 (1993) Prohibits research on or transplantation of an "unborn or newborn
Dakota child who has been subject to an induced abortion" except when the abortion is necessary
to protect the life of the woman.
Source: NCSL, LexisNexis, Statenet

Table 2. State’s Specific Policies on hESC Research with Aborted vs. Non- Aborted Embryos

State

Specifically Restricts research on
permits
aborted fetus/ embryo
research on
fetus/embryo

Consent provisions to conduct
research on fetus/embryo3

Arizona No

Yes, prohibits research on
aborted living/non-living
embryo or fetus

No

Arkansas No

Yes, prohibits research on
aborted live fetus

Yes, consent to conduct research on
aborted fetus born dead

Yes, prohibits research on
aborted live fetus

Yes, consent to donate IVF embryo to
research

No

Yes, consent to donate IVF embryo to
research

Florida No

Yes, prohibits on aborted
live fetus

No

Illinois Yes, permits

Yes, prohibits on aborted
living/
nonliving fetus

Yes, written consent to perform
research on cells or tissues from a dead
fetus other than from an abortion

California Yes, permits
research on
adult and
embryonic
stem cells
from any
source

Connecticut Yes, on
embryos
before
gastrulation (a
process
during
embryonic
development)

research on
embryonic
stem cells,
embryonic
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germ cells and
adult stem
cells from any
source

Indiana Yes, permits

Yes, prohibits research on
aborted living/non-living
embryo or fetus

Yes, consent required for fetal stem cell
research

No

No

Kentucky No

No

No

Louisiana No

No

No

Maine No

No

No

Yes, prohibits research on
embryo/live fetus

Yes, written consent to perform
research on a dead fetus and informed
consent to donate egg, sperm, or
unused preimplantation embryos
created for IVF

fetal stem cell
research on
placenta, cord
blood,
amniotic fluid
or fetal tissue

Iowa Yes, ensures
that Iowa
patients have
access to stem
cell therapies
and cures and
Iowa
researchers
may conduct
stem cell
research

Massachuse Yes, on
tts embryos that
have not
experienced
more than 14
days of
development
(not including
days frozen)
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Michigan No

Yes, live embryo/
fetus

Yes, written consent of mother to
donate dead embryo, fetus or neonate
to research

No

No

Missouri No

Yes, prohibits research on
a fetus alive pre-abortion

No

Montana No

Yes, prohibits research on
a live fetus

No

Nebraska No

Yes, prohibits research on
aborted live fetus or the
use of state funds for
research on fetal tissue
obtained from an abortion

No

No

No

No

Yes

No

No

No

No

Yes, prohibits research on
a living/non-living
embryo or fetus

Yes, requires consent to conduct
research on a nonliving fetus or embryo
other than from an abortion

Ohio No

Yes, prohibits research on
a living/non-living
embryo or fetus

No

Oklahoma No

Yes, prohibits research on
a fetus/embryo

No

Pennsylvani No
a

Yes, prohibits research on
a live embryo or fetus

Consideration may not be given to
mothers consenting to research; in

Minnesota No

New No
Hampshire
New Jersey Yes
New Mexico No
New York Yes, permits
research on
adult and
embryonic
stem cells
from any
source
North No

Dakota

50
cases involving abortion, consent must
be provided after decision to abort

Rhode No
Island
South No
Dakota

No

Yes

Yes, prohibits research on
a living/non-living
embryo or fetus

No

Tennessee No

No

Yes, consent required to conduct
research on aborted fetus

Texas No

No

No

Utah No

No

No

Virginia No

No

No

Wyoming No

No

No

Source: NCSL, LexisNexis, Statenet

C. Values in Conflict: Public Views on hESC Research
An individual’s support for hESC research is multidimensional, where the many ideologies that
the person holds can affect their view on hESC research. Among these underlying attributes are
religion, age, education, political ideology, socioeconomic status, and region.
Religion plays a major role in shaping the attitudes towards hESC research. Past survey research
has measured religious commitment as the frequency of attendance at religious services.

Respondents were asked about their general attendance to religious services (apart from funerals
or weddings) with the response options such as ‘more than once a week,’ or ‘at least once a
month.’ This measurement does oversimplify the complex and multifaceted nature of religious
faith and practice, however, it is the general measurement used across the many surveys
worldwide. The Pew Research Center Religion and Public Life Project's 2013 Survey on Aging
and Longevity found that respondents who consider religion very important to their lives, are
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more likely to be in opposition to hESC research (statistically significant). The survey also
showed that Evangelical Protestants were more likely to oppose hESC research compared to
Catholics.
The level of education and political ideology of an individual also plays a role in ones support
for hESC research. Pew Research Center surveyed thousands of Americans and found that those
with a higher level of education are more likely to support hESC research (Pew Research Center,
2005). Individuals were more likely to support hESC research if they were liberal Democrats.
40% of individuals identifying as conservative Republican showed support for hESC research,
while 85% of liberal Democrats supported hESC research (Pew Research Center, 2013).
A study Nisbet & Markowitz aimed to analyze the cross-sectional, nationally representative
survey data collected between 2002 and 2010 in order to better understand the relative influence
of political partisanship on Americans' support for hESC research. Figure 1 shows the results
from the study, showing that college educated Democrats are more likely to support hESC
research than non-college educated or Republican individuals.
Percent U.S. Adults Percentage by Partisanship and Education Supporting hESC Research

Percent U.S. Adults

Figure 1.
Percentage of
U.S. adults by
partisanship and
education who
favor embryonic
stem cell
research, 2002–
2010 (M. Nisbet
& Markowitz,
2014).

Year
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There are also generational differences in the opinion of the issue of hESC research. According
to a survey done by the Pew Research Center in 2005, younger people show a greater support for
hESC research than do older people (with 61% of those age 18-29 compared to 50% among
those 65 and older).
Income and race are other identifying factors in the support for hESC research. Past research has
shown that individuals with higher incomes are more likely to be supportive of hESC research.
Furthermore, white individuals are more likely to support hESC research than non-white, Black,
or Hispanic individuals (Pew Research Center 2005, 2013).
An individual’s region of residence also plays a minor role in their support for hESC research.
The main differences in these regions are the policies and culture within those regions, and
ethical positions on hESC research of those in that region. It was found that in the United States,
moral acceptability of the use of human embryos was the most influential driver of support for
hESC research. In Europe, the perceived benefit to society carried more weight, and in Canada,
moral acceptability and perceived benefit were almost equally important (Silber Mohamed,
2018).
Because moral acceptability is an important driver for the acceptance of hESC research, it is
important to review the public’s view on the status of the embryo and the extent of support for

hESC research in the US. When hESC research had its greatest public attention, a survey was
conducted in 2003 to gauge the publics’ opinion on the status of the embryo—58% of the public
appeared to believe that life begins as an embryo. Overall, 38 percent of Americans believe
hESC research is morally wrong—public support for research depends on the type of embryo
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used, with generalized public support greatest for “discarded” or “extra embryos” (M. C. Nisbet,
2004).
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VI.

Case Studies

Religion plays an important role in many people’s lives, and appeals to religion have been
prominent in the stem-cell debate, especially in the U.S. but also in some predominantly Catholic
European countries. Yet in the case of hESC research it does not always result in positions of
closure, pitting science against religion or religious against secular world-views. The following
pages will provide an in depth examination of two nations to create a better understanding of the
conflict between the secular, religious/cultural ideas in regards to hESC research. Turkey and
Brazil have both been chosen because each nation has conflicting cultural and political views on
hESC research.

A.

Turkey

The Republic of Turkey is a transcontinental country spanning Southeastern Europe and Western
Asia. The Turkish culture is very diverse—a mix between a modern western nation and a
traditional nation upholding its religious and historical values. Turkey’s diversity can in part be
attributed to its large number of refugees—hosting the largest number of refugees in the world.
According to UNHCR, in 2018 Turkey was hosting 63.4% of all the refugees in the world
(UNHCR, 2019). The nation has a principle of separation of powers where judicial power is
exercised by independent courts. Turkey is a secular nation with no official state religion,
however, about 99% of its population practices the Islamic faith. Turkey is very different from
many other Middle Eastern countries in that it separates the role of religion in legislation,
education, and public life. This difference can be attributed to the Kemalist view, which favors a
democratic, secular, and westernized view. Turkey ranks very high Human Development Index
due to its industrialized society and has a universal healthcare system in place. Total expenditure
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on health as a share of GDP in 2018 was the lowest among the 37 OECD (Organization for
Economic Co-operation and Development) countries (The World Bank, 2018). In regards to the
development of science, technology, and innovation policies in Turkey, TÜBİTAK is the leading
agency in governance of the specific research related laws.
Turkey’s overall policy opposes hESC research. The use of surplus embryos form IVF
treatments in hESC research is strictly prohibited. Instead, the Turkish Ministry of Health
requires that the excess embryos be destroyed after five years of preservation with the consent of
the donors (Arda & Aciduman, 2009). This prohibition of hESC research has been criticized by
some scholars in Turkey. It is not seen logical that while the destruction of the embryo is
permitted, its use for research and its benefit for human kind is not. Furthermore, Turkey’s policy
is not in accordance to the widely accepted Islamic view on hESC research—where the use of
surplus embryos for hESC research is permitted. The Islamic Fiqh Academy, Islamic Medical
Association of North America and the Fiqh council of the Muslim World League all favor the
use of surplus embryos in hESC research, just as the overwhelming majority of Turkish Muslim
scholars do. A study in 2016 interviewed the most prominent Muslim scholars in Turkey on their
opinions on hESC research. Fifteen Muslim scholars were interviewed-- nine scholars were
selected from academia, one was from the Director of Religious Affairs and five were
independent scholars. The study found that 93% of the Turkish Muslim scholars supported hESC
research with the excess embryos from IVF treatments (Karakaya & Ilkilic, 2016).
Muslim Turkish Scholars Embryos Can Be Produced for
hESC Research
Total (n=15)
Academia (n=9)
Religious Affairs (n=1)
Independent (n=5)

5
3
0
2

Excess Embryos from IVF Units
Can Be Used for hESC
Research
14
8
1
5
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Table 1. Positions of Turkish Muslim scholars towards embryonic stem cell research
One Turkish scholar argues in favor of hESC research based on the crucial Islamic principle of
seeking knowledge:
In the case of stem cell research, since it gives us a new opportunities to cure some
malignant diseases, the matter is no longer that of destroying embryos. It is a matter of
taking a new position in parallel with God’s desire, which here is to present us with new
therapeutic methods to cure diseases – while we did not know the therapeutic aspect of
embryonic stem cells before. Here, the question should be asked if it is morally
acceptable to act as if we did not know the therapeutic aspect of embryonic stem cells and
thus turn our back on medical problems. We cannot act anymore as if we did not have
this kind of knowledge (Karakaya & Ilkilic, 2016).
The main difference between the Turkish and other Islamic countries’ policy on hESC research
stems from their ethical perspectives on the status of the embryo. The general Islamic view is the
belief that the human embryo does not attain a moral status until after ensoulment (40-120 days
after conception). This is different from the predominant Turkish view that the human embryo is
ascribed a moral status at conception (Ozturk Turkmen & Arda, 2008). One Turkish scholar
points this out:
The real and logical beginning of the human being as an individual is the moment when
ovum and sperm, which originate as two separate and independent entities, fuse and
thereby activate a process to form a complete human being. Therefore, producing
embryos for stem cell research in the laboratory […], is not right from a religious
perspective (Karakaya & Ilkilic, 2016).
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While most Turkish scholars believe that the moral status of the embryo is ascribed at
conception, their argument regarding hESC research is not entirely weighed upon the moral
status of the embryo. Two other reference points play a major role in their ultimate decision to
support or reject hESC research—power of benefiting health in society, and the value of
knowledge. Seeking treatment and engaging in disease-preventing research are religious
responsibilities that will benefit humanity and thus is morally acceptable. Acquiring scientific
knowledge is also considered to have great value in the benefit of society and humankind. Both
of these principles are used by Turkish scholars to weigh with the moral status of the embryo to
decide whether to support or reject hESC research. Even though the Turkish scholars believe that
the human embryo attains a moral status at conception, almost all of them support the use of
surplus embryos in hESC research (Kanyış, 2020). This is because in the case of ‘doomed’
embryos, the Turkish Muslim scholars weigh the Islamic principles of seeking knowledge and
benefitting humankind over the moral status of the embryo.
Turkey’s policy in opposition to hESC research is in discord with the general Islamic
perspective. This can be partly attributed to the different views on the moral status of the human
embryo—causing a discrepancy in the policy of the nation. Furthermore, this can be partly
attributed to the kemalist nature of Turkish society and the secular code of moral and ethical
values which the nation of Turkey upholds as is involves its policies and governance (Silber
Mohamed, 2018).

B.

Brazil

Brazil is the largest nation in both South America and Latin America and is bordered by the
Atlantic ocean and other South American countries. Brazil’s culture is primarily a Westernized
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Portuguese culture and is one of the most diverse multicultural nations. About two-thirds of
Brazil’s citizens are Roman Catholic. Brazil has the largest share of global wealth in Latin
America and is an increasingly industrialized nation. The Brazilian public health system provides
universal healthcare to all of its citizens and is provided by all levels of government—being one
of the largest systems of its kind.
hESC research in Brazil faced major challenges during the 2004-2008 debate. In 2005, the
Lower House of Congress approved the Biosafety law and the Attorney General of the Republic,
a devout Catholic, pursued a ruling at the Supreme Court on the premise that the law is
unconstitutional and against the right of human embryos: “The central thesis in the present claim
is that human life happens in and starting with [the moment of] fertilization (Leite, 2006).” After
four years of debate in the Supreme Court, in 2008, the Brazilian Supreme Court approved hESC
research: “The Biosafety Law allows research using stem cells from human embryos produced
by in vitro fertilization, if the embryos have been frozen for more than three years and they
would be unlikely to survive when transferred to a woman’s uterus. In either case, progenitors
need to give permission” (Massarani, 2005).
Brazil’s policy on hESC research is in support of the matter—based on the nation’s Catholic
majority, this policy is in discord with the general Catholic view towards hESC research and the
status of the human embryo. Even though secularism made religious views personal matters, the
Catholic Church in Brazil still exerts a heavy force on the political matters within the nation.
During the hESC research debate in Brazil, two broad groups predominated—those in favor and
those in opposition. The pro-hESC research group was made up of doctors, scientists, and patient
advocacy activists. The anti-hESC research group was composed of members of the Catholic
Church, pro-life groups, conservative entities. These two groups framed their arguments and
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positions in very different ways—which led to the overall support of hESC research in the
Supreme Court ruling. The anti-hESC research group focused on their religious motivations and
positions (Mitre, 2015). They focused on arguing that life starts at conception, and thus making
hESC research an immoral and inhumane act.
There is undisputable scientific consensus that [life] starts at conception. The scientific
evidence is out there … When we think of a cluster of cells, what are we thinking? What
were these beings before the said 14 days of pregnancy? Or what animal or thing would
they be before 18 weeks …? (Brazil, 2007).
The pro-hESC research group focused heavily on scientific data, in hopes to dissociate hESC
research from abortion, and the humanitarian aspects of hESC research being the potential to
save lives of the sick and poor (Mitre, 2015). With these positions, the pro-hESC research group
was able to captivate the attention and support of the public. In 2008, the Public Opinion
Research Institute in Brazil conducted a survey about the public’s support for hESC research.
With almost 2,000 respondents, the survey showed that 75 percent of Brazilians were in favor,
with 1,230 respondents being Catholic and 386 being Evangelical (Jurberg et al., 2009). The prohESC research group’s humanitarian appeal and dissociation from abortion was fundamental for
the public’s support because the majority of the public comprised of Catholics willing to be
flexible with certain beliefs except abortion. Abortion was and still is a very sensitive topic to the
nation of Brazil and there are very strict policies on the matter. One of the strategies of the prohESC research group to dissociate hESC research from the concept of abortion is to avoid the
use of the term ‘embryo’ and instead use scientific terms like ‘blastocyte,’ or ‘microscopic cell.’
Furthermore, the use of the ‘potential to save lives’ argument by the Brazilian pro-hESC research
group was very effective by highlighting the ability to save many lives, who could benefit from
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hESC therapies (Mitre, 2015). Furthermore, the addition of the argument that the surplus
embryos from IVF treatments are discarded after a few years and instead can be beneficial in the
use of hESC research was a very powerful move by the pro-hESC research. With a moral
dilemma appeal, a pro-hESC research representative stated in court: “So how can we compare
the lives of these children, with that of frozen embryos? We don’t want to fight simply for
quality of life. We want to fight for life. And we cannot waste any more time. We don’t have the
right to take away their hopes for a cure. (Brazil, 2007).”
Even the President of the Chamber of Deputies, a conservative and devout Catholic, was
convinced of the powerful benefits of hESC to humankind and voted in favor of the matter
(Jurberg et al., 2009).
Another reason for the Supreme Court’s ruling for the support of hESC research is its passion for
upholding true democracy and secularism in the nation of Brazil. Some believed that prohibiting
hESC research would be the same as authorizing an anti-democratic intrusion of the Church in
matters of the government (Leticia Cesarino & Naara Luna, 2011).
Despite Brazil’s Catholic majority, with the powerful and strategic arguments of the pro-hESC
research group, and the publics’ support, the Supreme Court ruled to support hESC research on
the surplus embryos from IVF therapies. The mass support from the public and their excitement
for the increasingly secular and democratic nature of the nation and its governances, the
humanitarian appeal of hESC research, and its dissociation from the concept of destroying
human life all attributed to the ruling of the Brazilian Supreme Court on hESC research.
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VII.

Conclusion

Since Dr. J.A Thomson derived the first hESC line in 1988, the world of stem cell research
changed for all. For its self-renewing and pluripotent characteristics, hESCs quickly became a
very attractive source for research and eventually therapeutics. After many years of intense hESC
research, there have been major developments in the creation of therapeutics in regenerative
medicine, such as heart repair, multiple sclerosis, spinal cord injury, and Parkinson’s disease.
With these advancements, there have also been intense ethical and philosophical debates as it
pertains to the moral status of the human embryo. Some argue that human embryos have little to
no moral status because they lack characteristics, such as sentience or ability to feel pain and the
benefit of utilizing the human embryos outweighs the consequences. Others argue that it is
immoral to kill innocent humans and since human embryos are humans at conception, it is
immoral to destroy them. Different attributes of an individual play roles into affecting their
overall views on hESC research.
Among these attributes, religious and cultural traditions weigh most heavily when an individual
decides the moral status of the embryo and thus whether or not to support hESC research. An in
depth analysis of some different worldwide faith traditions including Judaism, Islam,
Christianity, Buddhism, and Hinduism, shows that each faith had very specific views on hESC
research based on their beliefs on the moral status of the embryo. In the Jewish, Islamic,
Buddhist, and Hindu faiths, hESC research is supported involving surplus embryos. However, in
the Christian faith, hESC research is not support in any form.
Furthermore, the investigation on the possible correlations between religious traditions and
national policies of different nations worldwide aimed to merely provide a better understanding
of the strength of the correlation between a nations predominant religious and cultural views and
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their policies on the matter. The hESC research policies of each nation is significant as it
provides a glimpse of the nation’s ethical, cultural, and political views and priorities.
Because of the many complicating factors, it is nearly impossible to attempt to make clear
conclusions about the religious and cultural traditions and their possible impact on regional or
national policymaking on hESC research. This is due to the wide array of viewpoints that can be
partly attributed to pluralistic nature of most religions where there is no centralized authority.
However, it is important to assess some factors that play a role in an individual’s view on hESC
research such as religion, age, education, political ideology, socioeconomic status, and region.
The examination of Turkey and Brazil’s conflict between their hESC research policies and their
secular, religious/cultural views aimed to provide a better understanding of the nation’s
priorities, ideals, and principles. In Turkey, the policy in opposition to hESC research contradicts
with the Islamic view in support of hESC research with surplus embryos. This was found to be
attributed to Turkey’s secular nature and their ethical perspectives on the status of the embryo.
Brazil’s policy in support of hESC research contradicted with the Christian view in opposition to
the matter. This was found to be mainly due to the increasingly secular nature of Brazil and the
mass support of the public on the issue during the ongoing debates in the years of 2004 to 2008.

There are many ongoing hESC research projects and clinical trials with treatments derived from
hESCs as of 2021. hESC research seems to be making progress, and in the near future is
predicted to be making major progression and success in the treatment of many different medical
conditions. However, there are many challenges that need to be overcome before the overall
widespread of hESC research. First, there needs to be a better understanding of the mechanism
by which stem cells function first in animal models. Next, for the widespread, global acceptance
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of the procedure, fear of the unknown is the greatest challenge to overcome. The efficiency of
stem cell-directed differentiation must be improved to make stem cells more reliable and
trustworthy for a regular patient. The scale of the procedure is another challenge. Future stem
cell therapies may be a significant obstacle. Transplanting new, fully functional organs made by
stem cell therapy would require the creation of millions of working and biologically accurate
cooperating cells. Although these challenges facing stem cell science can be overwhelming, the
field is making great advances each day. Stem cell therapy is already available for treating
several diseases and conditions. Their impact on future medicine appears to be significant.
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